NDRI is proud to announce that it has received the CAP Laboratory Accreditation from the Accreditation Committee of the College of American Pathologists. The National Disease Research Interchange is one of 8,000 CAP-accredited biorepositories worldwide. The accreditation supports NDRI’s commitment “…to the highest quality of service for the research community” said Melissa VonDran, PhD, Vice President of Operations and Biorepository Director.
The CAP Laboratory Accreditation Program, is a federally recognized program to assess and accredit biorepository facilities. The CAP Laboratory Accreditation Program is required to meet standards from Clinical Laboratory Improvement Amendments (CLIA), the FDA and OSHA. The CAP Program has the distinction of being equal to if not more stringent than the federal government’s own inspection program. The CAP Program is a highly rigorous set of guidelines utilizing “the latest best practices” under the direction of more than 500 pathologists.
CAP inspectors examine the laboratory’s records and procedural quality control for a two-year period prior to inspection. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety programs, records, and overall management. The CAP accreditation process is designed to ensure the highest standard of service, safety, and accuracy for lab results and patient diagnosis.
“This accreditation is testament to the dedication and shared commitment of all of our staff to assuring that the gifts with which we are entrusted to advance biomedical research are managed with the highest scientific standards,” said Bill Leinweber, president and CEO of NDRI.
Source: Laboratory Accreditation Program
